Eagle Health Investments’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-462,911
| Closed | -$5M | – | 21 |
|
|
2024
Q3 | $5M | Hold |
462,911
| – | – | 0.95% | 17 |
|
|
2024
Q2 | $9.72M | Hold |
462,911
| – | – | 1.7% | 20 |
|
|
2024
Q1 | $14.7M | Buy |
462,911
+25,000
| +6% | +$797K | 2.74% | 13 |
|
|
2023
Q4 | $8.87M | Hold |
437,911
| – | – | 1.8% | 16 |
|
|
2023
Q3 | $5.57M | Hold |
437,911
| – | – | 1.23% | 20 |
|
|
2023
Q2 | $7.91M | Hold |
437,911
| – | – | 1.48% | 20 |
|
|
2023
Q1 | $7.53M | Hold |
437,911
| – | – | 1.47% | 19 |
|
|
2022
Q4 | $9.73M | Buy |
437,911
+69,500
| +19% | +$1.54M | 2.24% | 15 |
|
|
2022
Q3 | $2.96M | Buy |
368,411
+106,988
| +41% | +$860K | 0.68% | 22 |
|
|
2022
Q2 | $1.83M | Buy |
261,423
+129,333
| +98% | +$903K | 0.43% | 23 |
|
|
2022
Q1 | $2M | Hold |
132,090
| – | – | 0.49% | 22 |
|
|
2021
Q4 | $2.9M | Buy |
132,090
+75,000
| +131% | +$1.65M | 0.71% | 22 |
|
|
2021
Q3 | $1.54M | Hold |
57,090
| – | – | 0.49% | 25 |
|
|
2021
Q2 | $1.38M | Buy |
57,090
+7,090
| +14% | +$171K | 0.47% | 29 |
|
|
2021
Q1 | $2.17M | Hold |
50,000
| – | – | 0.85% | 23 |
|
|
2020
Q4 | $2.07M | Buy |
+50,000
| New | +$2.07M | 1.33% | 21 |
|